These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12645856)

  • 1. Molecular basis of rifampicin-induced inhibition of anti-CD95-induced apoptosis of peripheral blood T lymphocytes: the role of CD95 ligand and FLIPs.
    Gollapudi S; Jaidka S; Gupta S
    J Clin Immunol; 2003 Jan; 23(1):11-22. PubMed ID: 12645856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis.
    Yerramasetti R; Gollapudi S; Gupta S
    J Clin Immunol; 2002 Jan; 22(1):37-47. PubMed ID: 11958592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis.
    Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T
    J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.
    Holmström TH; Schmitz I; Söderström TS; Poukkula M; Johnson VL; Chow SC; Krammer PH; Eriksson JE
    EMBO J; 2000 Oct; 19(20):5418-28. PubMed ID: 11032809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12.
    Lee SW; Park Y; Yoo JK; Choi SY; Sung YC
    J Immunol; 2003 Mar; 170(5):2456-60. PubMed ID: 12594270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of proapoptotic activity of soluble CD95 ligand is due to its failure to induce CD95 oligomers.
    Jang S; Krammer PH; Salgame P
    J Interferon Cytokine Res; 2003 Aug; 23(8):441-7. PubMed ID: 13678432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity.
    Kirchhoff S; Müller WW; Krueger A; Schmitz I; Krammer PH
    J Immunol; 2000 Dec; 165(11):6293-300. PubMed ID: 11086065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
    Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
    J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
    Shain KH; Landowski TH; Dalton WS
    J Immunol; 2002 Mar; 168(5):2544-53. PubMed ID: 11859150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC; de Vries EG; Vellenga E; de Jong S
    Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induced by disruption of the actin cytoskeleton is mediated via activation of CD95 (Fas/APO-1).
    Kulms D; Düssmann H; Pöppelmann B; Ständer S; Schwarz A; Schwarz T
    Cell Death Differ; 2002 Jun; 9(6):598-608. PubMed ID: 12032668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes.
    Uriarte SM; Joshi-Barve S; Song Z; Sahoo R; Gobejishvili L; Jala VR; Haribabu B; McClain C; Barve S
    Cell Death Differ; 2005 Mar; 12(3):233-42. PubMed ID: 15665818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of death-receptor induced caspase-8-activation in the death-inducing signalling complex by uncoupling of oxidative phosphorylation.
    Vier J; Gerhard M; Wagner H; Häcker G
    Mol Immunol; 2004 Jan; 40(10):661-70. PubMed ID: 14644092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes.
    Lens SM; Kataoka T; Fortner KA; Tinel A; Ferrero I; MacDonald RH; Hahne M; Beermann F; Attinger A; Orbea HA; Budd RC; Tschopp J
    Mol Cell Biol; 2002 Aug; 22(15):5419-33. PubMed ID: 12101236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
    Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
    Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.